Cytokinetics' neuro-degenerative drug fails late-stage trial
(Reuters) - Cytokinetics Inc said on Tuesday its drug to treat a type of neuro-degenerative disorder failed to meet the main goal of a late-stage trial.
from Reuters: Health News http://ift.tt/2hRTcYr
http://ift.tt/xePdMM